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A B S T R A C T
Retinitis pigmentosa (RP) is an inherited retinal degenerative disease. Mutations in EYS have been associated with autosomal recessive RP. The human iPS cell line,
CABi002-A, derived from peripheral blood mononuclear cells from a patient carrying a heterozygous double mutation in EYS gene was generated by non-integrative
reprogramming technology, using hOCT3/4, hSOX2, hc-MYC and hKLF4 reprogramming factors. Pluripotency and diﬀerentiation capacity were assessed by im-
munocytochemistry and RT-PCR. This iPSC line can be further diﬀerentiated towards the aﬀected cells to understand the pathophysiology of the disease and test new
therapeutic strategies.
Resource table
Unique stem cell line i-
dentiﬁer
CABi002-A
Alternative name(s) of
stem cell line
OF0176-EYS02-C7
Institution Andalusian Molecular Biology and Regenerative Medicine
Centre (CABIMER)
Contact information of
distributor
Francisco Diaz-Corrales, francisco.diaz@cabimer.es
Type of cell line iPSC
Origin Human
Additional origin info Age:38
Sex: Male
Ethnicity if known: Caucasian
Cell source Peripheral blood mononucleated cells
Clonality Clonal
Method of reprogram-
ming
Sendai viral reprogramming
Genetic modiﬁcation No
Type of modiﬁcation N/A
Associated disease Autosomal Recessive Retinitis Pigmentosa
Gene/locus EYS/6q12
c.3567delA
c.4829-4832delCATT
Method of modiﬁcation N/A
Name of transgene or r-
esistance
N/A
Inducible/constitutive s-
ystem
N/A
Date archived/stock da-
te
N/A
Cell line repository/ba-
nk
N/A
Ethical approval Patient informed consent obtained/Ethics Review Board-
competent authority approval obtained (Ethical Approval
number: PR-01-2015)
Resource utility
The generation of this cellular model will allow us to better un-
derstand the pathophysiology of the disease and to test new therapeutic
strategies for RP due to EYS mutations.
Resource details
Mononucleated cells were collected from 4ml of peripheral blood
sample from 38 year-old patient diagnosed with inherited con-rod
dystrophy, due to an heterozygous double mutation in EYS gene caused
by a deletion of an A in the position 3567 of the exon 23 of the paternal
allele (c.3567delA p.Gly1190Aspfs*39), originating a frame reading
change and premature STOP codon and a deletion of a CATT in the
position 4829–4832 of the exon 26 of the maternal allele (c.4829-
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4832delCATT p.Ser1610Phefs*7) (McGuigan et al., 2017). DNA se-
quencing of CABi002-A conﬁrmed the presence of the aforementioned
mutations (Fig. 1A). The human induced pluripotent stem (hiPS) cell
line was generated by using Sendai virus, encoding the reprogramming
factors hOCT3/4, hc-MYC, hKLF4, and hSOX2 (Takahashi et al., 2007),
according to manufacturer's instructions.
The obtained colonies presented stem-like morphology and plur-
ipotency markers Nanog, Oct4, and TRA-1-81 staining (Fig. 1C). The
clearance of viral and endogenous reprogramming markers (Fig. 1B), as
well as the presence of pluripotency genes (Fig. 1D), was conﬁrmed by
RT-PCR after eight cell culture passages. Our results on the karyotype
analysis showed that CABi002-A cell line exhibited a normal, diploid
(46, XY) chromosomal content (Fig. 1E) and the genetic ﬁngerprinting
proved the genetic identity to parental mononucleated blood cells (ar-
chived with journal). Pluripotency was tested by the ability of CABi002-
A to generate the three germ layers in vitro: endoderm, mesoderm and
ectoderm, as conﬁrmed by immunoﬂuorescent staining of α-fetoprotein
(AFP), vimentin and III beta-tubulin (Tuj1), respectively (Fig. 1F) and
RT-PCR (Fig. 1G).
Materials and methods
Mutation sequencing
Genomic DNA from peripheral blood mononuclear cells (PBMCs)
and hiPSCs was isolated using the QIAamp DNA Blood mini kit
(Qiagen). Primers used for ampliﬁcation and directed sequencing of
EYS ﬂanking the mutation sites are described in Table 1.
Reprogramming of PBMCs
PBMCs were isolated using the Vacutainer® CPT™ tubes (BD
Biosciences). PBMCs were cultured (1.0× 106 cells) in Expansion
Medium (EM; QBSF-60 medium; 50 μg/ml ascorbic acid, 1% Pen/Strep,
50 ng/ml SCF, 10 ng/ml IL-3, 2 U/ml EPO, 40 ng/ml IGF-1 and 1 μM
Dexamethasone), for one week before transduction with CytoTune®-iPS
2.0 Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc). Brieﬂy,
0.25×105 cells were transduced using MOI of 5–5-3 (hKOS, hc-MYC,
hKLF4, respectively). After 24 h of incubation cells were collected,
centrifuged and seeded in a 24 well plate containing EM. Two days later
Fig. 1. Characterization of CABi002-A line. A. DNA electropherograms showing the heterozygous double mutation c.3567delA and c.4829-4832delCATT of EYS gene
in CABi002-A hiPS cell line of a RP patient. B. RT-PCR analysis of SeV genome and transgenes in hiPSCs, PBMC's (monocytes) and positive control (+ Control). C.
Immunocytochemistry for pluripotency markers NANOG, OCT4 and TRA-1-81. Nuclei were counterstained with DAPI. Lower panel (left) is a brightﬁeld image of a
CABi002-A hiPS colony, showing its normal morphology and (right) quantiﬁcation by qPCR of pluripotency markers NANOG and OCT3/4 of CABi002-A hiPS
cells compared, compared to PBMC's (monocytes). D. RT-PCR analysis of pluripotency markers. E. Representative metaphase of normal human karyotype (46, XY). F.
Immunocytochemistry for ectodermal (Tuj1), mesodermal (ASM) and endodermal (AFP) germ layer markers with nuclei counterstained with DAPI. G. RT-PCR
analysis of the three germ layer markers.
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0.1×106 cells were transferred onto a 6 well plate covered with
0.25×106 irradiated human foetal ﬁbroblasts (irHFF) in QBSF-60
medium, supplemented with 50 μg/ml ascorbic acid and 1% Pen/Strep.
Seven days post-transduction, culture medium was replaced by iPS
medium (KO DMEM, 20% KO serum, 1% GlutaMAX; 1% MEM NEAA,
0.23mM β-mercaptoethanol, 1% Pen/Strep, 10 ng/ml bFGF).
Individual colonies with stem-like morphology were manually isolated
and expanded 21 to 27 days post-transduction. hiPS cell cultures were
cultured on 6 well plate coated 0.25×106 irHFF, maintained at 37 °C
in humidiﬁed atmosphere containing 5% CO2, and passed every week.
RT-PCR for detection of viral clearance and pluripotency markers
Total RNA was isolated from cultured hiPS cells with RNeasy Mini
Kit (Qiagen) and treated with DNase1 to remove genomic DNA con-
tamination. 1 μg of total RNA was used as template to obtain cDNA,
using QuantiTect Reverse Transcription Kit (Qiagen). Viral clearance
and pluripotency markers detection were analyzed using the primers
described in Table 1. RT-PCR reaction was performed using MyTaq
DNA Polymerase (Bioline GmbH). PCR products were analyzed on 2%
agarose gels.
Three linage diﬀerentiation
In vitro diﬀerentiation was performed by embryoid body (EB) for-
mation to generate the three germ layers (endoderm, mesoderm and
ectoderm). The hiPS cells were separated manually from the feeder cells
and cultured in non-adherent conditions in iPS medium without bFGF
(KO DMEM, 20% KO serum, 1% GlutaMAX; 1% MEM NEAA, 0.23mM
β-mercaptoethanol, 1% Pen/Strep) for the following 7 days. Then, the
EBs were seeded on glass coverslips treated with 0,1% gelatin for 2 h/
RT and cultured during one week in EBs medium (DMEM/F12, 10%
FBS, 1% GlutaMAX, 1% MEM NEAA, 1% Pen/Strep). The coverslips
were ﬁxed in 4% PFA for 15min and analyzed by immunoﬂuorescence.
Immunocytochemistry
Cells were allowed to grow in glass coverslips coated with irHFF and
washed in ice-cold PBS before ﬁxation in 4% PFA, for 15min. Fixed
cells were washed twice in PBS and placed in blocking solution (2%
donkey serum in 0.2% Triton-X100/PBS) for 1 h at room temperature.
Cells were incubated for 1 h at room temperature with the primary
antibody (Table 1). After incubation, samples were washed 3 times in
0.2% Triton X100/PBS, and incubated with the secondary antibodies at
room temperature for 1 h (Table 1). After 3 washes, coverslips were
mounted with Vectashield mounting medium (Vector H-1200) con-
taining 4,6-diamidino-2-phenylindole (DAPI).
Karyotype analyses
Genome integrity of the hiPS cells was analyzed by G-banding at
400–550 band resolution (Biobanco de Sistema Sanitario Público,
Granada, Spain).
Fingerprinting
gDNA form PBMC's and hiPS cells was extracted using QIAamp DNA
Blood mini kit (Qiagen) in the presence of RNAse (Roche).
Fingerprinting analyses was performed by Biobanco de Sistema
Sanitario Público, Granada, Spain.
Table 1
Reagents details.
Antibodies used for immunocytochemistry/ﬂow-citometry
Antibody Dilution Company Cat # and RRID
Pluripotency markers Rabbit anti-OCT4 1:400 Cell Signaling Technology Cat# 2840, RRID:AB_2167691
Rabbit anti-NANOG 1:400 Cell Signaling Technology Cat# 4903, RRID:AB_10559205
Rabbit anti-SOX2 1:400 Cell Signaling Technology Cat# 3579, RRID:AB_2195767
Mouse anti-SSEA-4 1:100 BD Biosciences Cat# 560073, RRID:AB_1645601
Mouse anti-TRA-1-81 1:100 Stemgent Cat# 09-0069, RRID:AB_2119069
Diﬀerentiation markers Rabbit anti- Tuj1 1:2000 Covance Research Products Inc. Cat# MRB-435P-100, RRID:AB_663339
Mouse anti-ASM 1:300 Sigma-Aldrich Cat# A5228, RRID:AB_262054
Mouse anti-AFP 1:20 Sigma-Aldrich Cat# A5228, RRID:AB_262054
Secondary antibodies Donkey anti-Mouse 488 1:500 Molecular Probes Cat# A-21202, RRID:AB_141607
Donkey anti-Rabbit 594 1:500 Molecular Probes Cat# A-21207, RRID:AB_141637
Primers
Target Forward/Reverse primer (5′-3′)
Plasmids (RT-PCR) SeV plasmid GGATCACTAGGTGATATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
KOS plasmid ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
KLF4 plasmid TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
c-MYC plasmid TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
Pluripotency markers (RT-PCR) NANOG CCAAATTCTCCTGCCAGTGAC/CACGTGGTTTCCAAACAAGAAA
OCT4 AAGCCCTCATTTCACCAGG/CTTGGAAGCTTAGCCAGGTC
SOX2 TCACATGTCCCAGCACTACC/CCCATTTCCCTCGTTTTTCT
TERT GCGTTTGGTGGATGATTTCT/GGCATAGCTGGAGTAGTCGC
Diﬀerentiation Potential (RT-PCR) PAX6 GTCCATCTTTGCTTGGGAAA/TAGCCAGGTTGCGAAGAACT
MAP2 GCACGCCTGCAGCTTGCATC/TCTCCACCACCCCGTACGCA
BRACHYURY TCAGCAAAGTCAAGCTCACCA/CCCCAACTCTCACTATGTGGATT
MSX1 CGAGAGGACCCCGTGGATGCAGAG/GGCGGCCATCTTCAGCTTCTCCAG
α-FETOPROTEIN CTTTGGGCTGCTCGCTATGA/ATGGCTTGGAAAGTTCGGGTC
SOX17 CGCTTTCATGGTGTGGGCTAAGGACG/TAGTTGGGGTGGTCCTGCATGTGCTG
House-Keeping genes (RT-PCR) GAPDH TGCACCACCAACTGCTTAGC/GGCATGGACTGTGGTCATGAG
Genotyping EYS exon 23 TCCCAGCTACATGTTGTTG/CATTAAGATTTCCTGATGAAAGC
EYS exon 26 CAAGCAACCAGAGACTCA/TGTGAAGGGACAATGGATAAAC
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Mycoplasma detection
The presence of mycoplasma was tested regularly by luminescence
using the MycoAlert™ PLUS Mycoplasma Detection Kit (Lonza).
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